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Abstract
We have investigated the effect of glucose deprivation treatment on the activation of mitogen activated protein kinases (MAPKs)
in the drug-sensitive human breast carcinoma cells (MCF-7) and its drug resistant variant (MCF-7/ADR) cells. Western blots
and in-gel kinase assays showed that glucose free medium was a strong stimulus for the activation of MAPK in MCF-7/ADR
cells. No activation was seen in MCF-7 cells. MAPK was activated within 3 min of being in glucose free medium and it re-
mained activated for over 1 h in MCF-7/ADR cells. After being returned to complete medium, 1 h was required for the MAPK
to become deactivated. To investigate whether alternative sources of ATP could inhibit glucose deprivation induced MAPK
activation, we added glutamine and glutamate to glucose deprived medium. The addition of glutamine did not reverse glucose
deprivation induced MAPK activation in MCF-7/ADR cells. The addition of glutamate, however, decreased the MAPK acti-
vation and the length of time of activation. We observed an increase greater than three fold in MEK, Raf, Ras, and PKC activ-
ity with glucose deprivation in MCF-7/ADR cells. This suggests that glucose deprivation-induced MAPK activation is mediated
through this signal transduction pathway. (Mol Cell Biochem 170: 23–30, 1997)
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Introduction
Angiogenic factor-related genes such as basic fibroblast
growth factor (bFGF) contain AP-1 cis-acting regulatory
elements (TPA response elements; TRE) in their promoter
region [1]. These regulatory elements are recognized by AP-
1 transcription factors (Jun and Fos family proteins) [2]. The
induction of jun and fos gene transcripts and post-transla-
tional modification of their products regulates the activity of
AP-1 transcription factor [3]. Environmental stresses such as
heat shock exposure [4], UV-irradiation [5], ionizing radia-
tion exposure [6, 7], and treatment with chemical agents [4,
5] have been shown to induce -jun and c-fos gene expres-
sion in mammalian cells. Recent work from this laboratory
has shown that stress induced bFGF gene expression is me-
diated through the activation of protein kinase C (PKC) and
AP-1 transcription factors (Jun and Fos) [8, 9].
A fundamental question that remains unanswered is how
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the stresses stimulate the synthesis and/or post-translational
modification of Jun and Fos. It is known that phosphoryla-
tion of c-jun at two serine residues (ser-63 and 73) results in
the activation of c-jun [10]. Mitogen activated protein kinases
(MAPKs) also known as extracellular protein kinases (ERKs)
have been proposed to play a role in this phosphorylation
[11]. MAPK is also involved in the transcriptional regulation
of c-fos. The transcription of c-fos is mediated by two major
cis-elements, the serum response element (SRE) and the c-
sis conditioned medium induction element (SIE). The SIE
interacts with activated Stat3, a member of the STAT (signal
transducer and activator of transcription) family of transcrip-
tion factors [12]. MAPK has been shown to be involved in
the activation of STAT [13]. The SRE is recognized and sta-
bly found by a homodimer of serum response factor (SRF)
[14]. The binary SRE-SRF complex interacts with another
factor, the ternary complex factor (TCF) [15]. The activity
of TCF is rapidly increased in response to cell stimulation
with agents such as growth factors which led to MAPK acti-
vation. MAPK appears to be responsible for the phosphor-
ylation of TCF [16] and subsequently its transcriptional
activity [17]. Thus, in an effort to elucidate how environment
stress induces angiogenesis, we propose that environmental
stress activates MAPK.
We have previously shown that glucose deprivation acti-
vates the expression of c-jun and c-fos genes which results
in an increase in AP-1 activity and subsequent bFGF gene
expression in the drug-resistance human breast carcinoma
MCF-7/ADR cells [9]. We hypothesized that the induction
of these gene expressions by glucose deprivation was medi-
ated through the activation of MAPK. To test our hypothesis,
we used MCF-7/ADR cells and compared them to the drug
sensitive human breast carcinoma MCF-7 cells. We observed
differences in cellular response between these two cell lines
with glucose deprivation. Whereas glucose deprivation in
MCF-7/ADR cells resulted in cytotoxicity, little/no effect was
observed in MCF-7 cells (unpublished data). Furthermore,
we have previously shown that radiation induced expression
of c-jun, c-fos, and bFGF genes is more prominent in MCF-
7/ADR cells than in MCF-7 cells [8]. In this study, we ob-
served MAPK activation with glucose deprivation in MCF-7/
ADR cells but not in MCF-7 cells. We also observed an in-
crease in MEK, Raf, Ras, and PKC activity in MCF-7/ADR
cells with glucose deprivation. It is hypothesized that the
activation of this signal transduction pathway is responsible
for the cytotoxicity in MCF-7/ADR cells with glucose dep-
rivation. At a time when intracellular ATP levels are depleted,
the cell is signalling for increased protein synthesis leading
to an incompatible signal transduction and cell death. Cer-
tainly, further work is needed to elucidate the exact mecha-
nism by which this is mediated; in this paper, however, we
present the involvement of MAPK. This model will also pro-
vide a framework for future studies.
Materials and methods
Cell culture
Human breast carcinoma cells (MCF-7) and its multidrug-
resistant subline (MCF-7/ADR) were elucidated in McCoy’s
5a medium (Cellgro) with 10% iron-supplemented bovine
calf serum (HyClone Laboratories, Logan, UT) and 26 mM
sodium bicarbonate for monolayer cell culture. Two or three
days prior to the experiment, cells were plated into 35 mm
petri dishes, T-150 flasks, or T-75 flasks. The petri dishes/
flasks containing cells were kept in a 37°C humidified incu-




Cells were rinsed three times with Hanks’ balanced salt so-
lution (HBSS). Cells were treated with glucose-free McCoy’s
5A medium (Gibco BRL, Gaithersburg, MD) for the speci-
fied time intervals.
Drug treatment
Glutamine and glutamate were obtained from Sigma Chemi-
cal Co (St. Louis, MO). Drug treatment was accomplished by
aspirating the medium and replacing it with medium contain-
ing the drug. The drug treatment was terminated by aspiration
of the medium and rinsing the cells 3 times with HBSS.
Polyacrylamide gel electrophoresis
Samples were mixed with 2 × Laemmli buffer (1 × buffer:
2.4 M glycerol; 0.14 M Tris, pH 6.8; 0.21 M sodium dodecyl
sulfate (SDS); 0.3 mM bromophenol blue), and boiled for 5–
15 min. Protein content was measured with BCA protein
assay reagent (Pierce, Rockford, IL). The samples were di-
luted with 1 × lysis buffer containing 1.28 M β-mercapto-
ethanol and an equal amount of protein (30 µg) was applied
to a one dimensional PAGE. Electrophoresis was carried out
on 10–18% linear gradient SDS-polyacrylamide gels [18].
Western blot
Proteins that were separated by SDS-PAGE were transferred
onto a nitrocellulose membrane by electroblotting. The trans-
fer was performed at a current of 0.12 A at 30 V overnight.
The membrane was incubated in blocking solution (3% bo-
vine albumin; 20 mM Tris, pH 7.5; 400 mM NaCl; 0.05%
Tween-20) for 1 h at 37°C, washed, and then incubated with
the MAPK monoclonal antibody (Gibco BRL, 1:500 dilu-
tion). The primary antibodies were diluted with diluting so-
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lution (1% bovine albumin; 20 mM Tris, pH 7.5; 400 mM
NaCl; 0.05% Tween-20). After incubation with the primary
antibody, the membrane was washed 3 times for 5 min each
in TBST (20 mM Tris, pH 7.5; 400 mM NaCl; 0.05% Tween-
20), and incubated with alkaline phosphatase-conjugated
rabbit anti-mouse IgG in the diluting solution at 1:3000 for
1–2 h. The membrane was then stained using nitro blue
tetrazolium (NBT) and 5′-bromo-4-chloro-3-indolylphos-
phate (BCIP) solution.
In-gel kinase assay
A 10% acrylamide SDS-PAGE gel was made with 0.1 mg/
ml myelin basic protein embedded within. The samples were
prepared as for the polyacrylamide gel electrophoresis de-
tailed above, loaded and electrophoresed [19]. The gel was
washed with 50 mM Hepes, pH 7.4; 5 mM 2-mercapto-
ethanol; and 20% isopropanol for 1 h at room temperature 2
times. The next wash was with 50 mM Hepes, pH 7.4 and 5
mM 2-mercaptoethanol for 1 h at room temperature. This was
followed by a wash in 50 mM Hepes, pH 7.4; 5 mM 2-
mercaptoethanol; and 6 M guanidine chloride for 1 h at room
temperature repeated once. The gel was then washed with 50
mM Hepes, pH 7.4; 5 mM 2-mercaptoethanol; and 6 M gua-
nidine chloride for 1 h at room temperature repeated once.
The gel was then washed with 50 mM Hepes, pH 7.4; 5 mM
2-mercaptoethanol; and 0.04% tween-20 for 16 h at 4°C with
two changes of solution. The final wash was carried out in
25 mM Hepes, pH 7.4; 5 mM 2-mercaptoethanol; 10 mM
MgCl
2
; and 90 µM sodium vanadate for 30 min at 30°C.
Phosphorylation of the gel was carried out in 25 mM Hepes,
pH 7.4; 5 mM 2-mercaptoethanol; 10 mM MgCl
2
; 90 µM
sodium vanadate; 50 µM ATP; and 150–250 µCi 32P-ATP for
30 min at 30°C. The gel was washed with 5% TCA and 10
mM sodium pyrophosphate until the background was low.
The gel was dried and autoradiographed.
MEK activity assay
Cells were washed twice with ice cold PBS and harvested in
IP buffer (25 mM Hepes, pH 7.5; 0.2 mM PMSF; 0.05% 2-
mercaptoethanol; 1% triton; 2 mM sodium vanadate; 50 mM
NaF; proteinase inhibitors of leupeptin and chymostatin; and
the trypsin inhibitor aprotinin). The cells were sonicated and
the lysate centrifuged for 10 min at 10,000 rpm in a microfuge.
The supernatant (1 mg protein) was incubated with 2 µl of
anti-MEK antibody (K.L. Guan, University of Michigan) for
2 h at 4°C. 40 µl of protein A agarose (Pierce) was added in
the immunoprecipitation reaction and incubated at 4°C for
an additional 1 h. The samples were centrifuged for 2 min at
4,000 rpm and washed with IP buffer (minus proteinase in-
hibitors) four times. The immunoprecipitates were washed
once with kinase buffer (18 mM Hepes, pH 7.5; 10 mm
magnesium acetate). The immunoprecipitated MEK was in-
cubated in 20 µl of kinase buffer with 50 mM ATP and 0.3
µg of purified ERK1 for 30 min at 30°C with gentle shak-
ing. The myelin basic protein (MBP) kinase assay of the
activated ERK1 was performed in 40 µl kinase buffer con-
taining 1.5 µCi 32P-γ ATP and 20 µg of MBP for 20–30 min
at 30°C. 20 µl of the sample was spotted onto a p81 phospho-
cellulose paper and washed 4 times with 80 mM phosphate
solution followed by one wash with 95% ethanol. The amount
of P32 incorporated in MBP was determined by liquid scin-
tillation counting.
Raf activity assay
The samples were immunoprecipitated as for MEK assay
except that 2 µg of anti-Raf antibody (Santa Cruz) was used.
The immunoprecipitated Raf was incubated in 20 µl of ki-
nase buffer with 50 mM ATP and 0.3 µg of purified GST-
MEK1 (K.L. Guan, University of Michigan) for 30 min at
30°C with gentle shaking. The activated GST-MEK1 was
used to activate 0.3 µg of purified ERK1 in 20 µl of kinase
buffer with 50 mM ATP for 10 min at 30°C with gentle shak-
ing. The MBP kinase assay of the activated ERK1 was per-
formed as in the MEK assay.
Ras activity assay
Cells were grown in 60 mm petri dishes and washed with
phosphate buffered saline (PBS). These cells were then in-
cubated in phosphate free McCoy’s containing dialyzed se-
rum for 45 min. The medium was replaced by phosphate free
McCoy’s containing 0.25 mCi 32P-orthophosphoric acid per
1 ml and incubated for an additonal 3 h. The cells were then
washed twice with warm Hank’s solution, incubated in glu-
cose free medium for 5 min, and washed twice with cold PBS.
Lysis of the cells was performed in 500 µl of lysis buffer (50
mM Tris buffer, pH 7.4; 20 mM MgCl
2
; 150 mM NaCl; 1%
NP-40; 2 mM PMSF; 10 µg/ml leupeptin; 10 µg/ml aprotinin;
1 µg/ml pepstatin A; 2 mM vanadate) containing 20 µg of
monoclonal rat-anti-Ras antibody (Oncogene Science, Cam-
bridge, MA). Nuclei were removed by centrifugation. The
supernatant was incubated at 4°C for 2 h with mixing on
rotating wheel. 50 µl of Protein G Agarose (Oncogene Sci-
ence, Cambridge, MA) linked to goat anti rat-IgG (Oncogene
Science, Cambridge, MA) was added and the mixture further
incubated for 1 h. The beads were washed four times with
lysis buffer and once with PBS. The pellet was resuspended




, pH 3.4 and boiled for 5 min.
Separation of the GTP and GDP Ras was on PEI-cellulose
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, pH 3.4. Autoradiography was
then performed.
PKC activity assay
Amersham’s PKC enzyme assay system was used to deter-
mine the PKC activity in each sample. Cells were mixed with
extraction buffer (50 mM Tris-HCl, pH 7.5, 5 mM EDTA, 10
mM EGTA, 0.3% w/v β-mercaptoethanol, 50 µg/ml PMSF,
1 µg/ml leupeptin), sonicated, and then centrifuged. Super-
natant was saved and mixed with glycerol for storage. Pro-
tein content was determined by the Bradford method [20].
The reaction buffer (calcium buffer, lipid, peptide buffer, and
DTT buffer) was added to the sample (50–100 µg of protein).
The reaction was started by adding γ32P-ATP and continued
for 15 min at 25°C. The reaction was terminated by adding
the stop reagent. One hundred µl of the reaction mixture was
blotted onto cellulose filter paper. The filter paper was rinsed
with acetic acid three times and then air dried. The filter paper
was counted in a scintillation counter.
Results
Glucose deprivation-induced MAPK activation
Mitogen activated protein kinases (MAPKs) also known as
extracellular regulated protein kinases (ERKs) are modulated
via phosphorylation and dephosphorylation at tyrosine and
threonine residues [21]. Activation of MAPK, thus, changes
the mobility of the protein on SDS-PAGE and on Western blot
this can be visualized with the activated form having a MW
of 44 kDa and the inactive form having a MW of 42 kDa [22].
Two distinct MAPKs (ERK1 and ERK2) have been isolated
and amino acid sequencing has shown that they are 90%
homologous [23]. The response to stimuli for both is similar
and in this paper we report results specifically for ERK2. The
Western blot in Fig. 1 depicts MAPK activation with differ-
ent medium conditions in MCF-7 and MCF-7/ADR cells. We
observed little or no activation of MAPK in MCF-7 cells (Fig.
1A). In MCF-7/ADR cells, however, a low level of activa-
tion can be seen with dialyzed serum and full serum (Fig. 1B,
lanes 3 and 4). Glucose free medium alone caused a strong
activation of MAPK (Fig. 1B, lane 5). Full medium by itself
resulted in little or no activation (Fig. 1B, lane 6). Both glu-
cose free medium containing dialyzed serum (Fig. 1B, lane
7) and full medium containing full serum (Fig. 1B, lane 8)
caused an activation of MAPK. Figure 2 shows an in-gel
MAPK assay with various medium conditions in MCF-7 and
MCF-7/ADR cells. MCF-7 cells again show little or no acti-
vation of MAPK (Fig. 2A). The MCF-7/ADR cells show
strong activation with glucose free medium (Fig. 2B, lane 2)
and glucose free medium containing dialyzed serum (Fig. 2B,
lane 4). Full medium alone (Fig. 2B, lane 3) did not cause
activation and full medium containing full serum (Fig. 2B,
lane 5) caused small activation. There is somewhat of a dis-
crepancy in the data with full medium containing full serum
between the Western blot (Fig. 1B, lane 8) and the in-gel
MAPK assay (Fig. 2B, lane 5) to the level of MAPK activa-
tion. Further work is needed to clarify this issue.
Fig. 1. MAPK activation in MCF-7 and MCF-7/ADR cells with various
medium conditions. Lysates from an equal amount of protein (30 µg) were
separated by SDS-PAGE, transferred onto nitrocellulose membrane and
processed for immunoblotting with an anti-ERK2 antibody. Lane 1 is con-
trol and contains extracts from cells that were washed with HBSS three
times. All of the other lanes contain extracts from cells that were washed 3
times with HBSS and then incubated for 10 min in HBSS (lane 2), HBSS
containing dialyzed serum (lane 3), HBSS containing full serum (lane 4),
glucose free medium only (lane 5), full medium only (lane 6), glucose free
medium containing dialyzed serum (lane 7), and full medium containing
full serum (lane 8). The activated MAPK is marked by the arrow head and
the inactive one is marked by the arrow.
Fig. 2. In-gel MAP Kinase assay of MCF-7 and MCF-7/ADR cells with
various medium conditions. The in-gel kinase assay was carried out as
described in materials and methods of MCF-7 (panel A) and MCF-7/ADR
(panel B) cells after having been washed with HBSS 3X and incubated for
10 min in HBSS containing full serum (lane 1), glucose free medium only
(lane 2), full medium (lane 3), glucose free medium containing dialyzed
serum (lane 4), and full medium containing full serum (lane 5).
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Time course for activation and deactivation
The time course for activation is shown in Fig. 3A. MCF-7/
ADR cells showed MAPK activation in 3 min after being in
glucose free medium. This activation was maintained for
more than 1 h if still incubated in glucose free medium (Fig.
3B). Once removed from glucose free medium and replaced
with full medium, deactivation of MAPK started to occur
immediately but took upto 1 h to completely return to the
normal deactivated state (Fig. 3B).
Effect of glucose, glutamine and glutamate on MAPK
activation
The concentration of glucose  in full medium is 17.7 mM.
We investigated the effect of various concentrations of glu-
cose on MAPK activation. In Fig. 4, it can be seen that glu-
cose concentrations less than 10 mM resulted in strong
MAPK activation. Since glutamine is known to be a replace-
ment for glucose as a source of ATP, we added it to glucose
deprived medium to see if we could reverse glucose depri-
vation induced MAPK activation. As seen in Fig. 5, no ef-
fect of glutamine was noted at concentrations upto 10 mM.
We similarly looked at glutamate except we also did a time
course experiment (Fig. 6). At concentrations of 10.5 mM,
there is still activation of MAPK but there is a large amount
that is inactive and it appears to become inactive at a shorter
time interval.
Glucose deprivation-induced MEK, Raf, Ras, and PKC
activity
We wanted to further study the pathway by which glucose
deprivation causes MAPK activation. We, therefore, investi-
gated some of the upstream elements. Figure 7 shows the
Fig. 3. Time course of glucose deprivation-induced MAPK activation and deactivation. Panel A: MCF-7 and MCF-7/ADR cells were washed with HBSS three
times and incubated in glucose free medium for the intervals (0.5, 1, 2, 3, 4, and 6 min) indicated at the bottom of each lane; Panel B: -Glucose: MCF-7/ADR
cells were washed 3 × with HBSS and incubated in glucose free medium for the intervals (10, 15, 20, 30, 45, and 60 min) indicated at the bottom of each lane.
Glucose 1 h –>t: MCF-7/ADR cells were washed 3 × with HBSS and incubated in glucose free medium for 1 h. The medium was then replaced with full medium
for the intervals (10, 15, 20, 30, 45, and 60 min) indicated at the bottom of each lane. Western blot analysis was done as described in Fig. 1.
Fig. 4. The effect of the concentration of glucose on MAPK activation.
Glucose free medium was supplemented with glucose to make the concen-
trations (0.001, 0.01, 0.1, 1, 10, 20, 50, 80, and 100 mM) indicated at the
bottom of each lane. MCF-7/ADR cells were washed with HBSS 3 × and
incubated in their respective medium for 10 min each. Western blot analy-
sis was done as described in Fig. 1.
Fig. 5. The effect of the addition of Glutamine on glucose deprivation-
induced MAPK activation. Glucose free medium was supplemented with
glutamine to make the concentrations (0.0001, 0.001, 0.01, 0.1, 1, and 10
mM) indicated at the bottom of each lane. MCF-7/ADR cells were washed
with HBSS 3 × and incubated in their respective medium for 10 min. West-
ern blot analysis was done as described in Fig. 1.
Fig. 6. The effect of the addition of Glutamate on glucose deprivation-
induced MAPK activation. Glucose free medium was supplemented with
glutamate to make the concentrations 1.5 and 10.5 mM as indicated at the
top of the sections. MCF-7/ADR cells were washed with HBSS 3 × and
incubated in this medium for 5, 10, 30, 60, or 120 min as indicated at the
bottom of each lane. Western blot analysis was done as described in Fig. 1.
28
Fig. 7. MEK, Raf, Ras and PKC activity in MCF-7/ADR cells. MEK (panel A), Raf (panel B), Ras (panel C), and PKC (panel D) activity were measured as
described under materials and methods in MCF-7/ADR cells under normal conditions (control) and after being in glucose free medium for 4–5 min (-glucose)
as labelled at the bottom of each graph.
changes that occur in MEK, Raf, Ras and PKC activity after
being in glucose free medium for 4–5 min. MEK activity in-
creased by 3 fold (Fig. 7A). Both Raf-b and Raf-c were looked
at and their activity increased by 4 fold (Fig. 7B). The Ras
activity was obtained from densitometric analysis of the
autoradiograph of the TLC separated samples (data not shown).
The percent active Ras increased 4.5 times (Fig. 7C). Similarly,
a 14 fold increase in PKC activity was also seen (Fig. 7D).
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Discussion
In this study, we have observed that mitogen activated pro-
tein kinases (MAPKs) are activated in response to glucose
deprivation in drug resistant human breast carcinoma (MCF-
7/ADR) cells. This activation occurred in 3 min after being
in glucose free medium (Fig. 3A) and was maintained for
more than 1 h if still incubated in glucose free medium (Fig.
3B). MAPKs also known as extracellular regulated protein
kinases (ERKs) are protein kinases having molecular masses
of 42–45 kDa that are stimulated in response to a wide range
of stimuli [24]. The best studied of these kinases are p42MAPK
(ERK2) and p44MAPK (ERK1) [25]. We have presented our
data specifically for ERK2, however, experiments done us-
ing ERK1 showed similar results (data not shown).
It is well known that stimuli which promote growth and
differentiation in cells activate MAPK. These include growth
factors like epidermal growth factor (EGF) [22, 26] and plate-
let derived growth factor (PDGF) [26] or hormones like in-
sulin [27] and progesterone [28]. It is also known that
nonmitogenic stimuli can activate MAPK. These include
thrombin [29], bradykinin [30], osmotic shock [31], ioniz-
ing radiation [32], and oxidant treatment [33]. We have here
shown that glucose deprivation in MCF-7/ADR cells can also
activate MAPK.
Glucose as an energy source is crucial for cell growth. It
has been shown that glucose deprivation in an interleukin 3
dependent cell line resulted in programmed cell death or
apoptosis [34]. Glutamine as an alternative energy source
could prevent this. In our data, the addition of glutamine did
not reverse glucose deprivation induced cytotoxicity (unpub-
lished data) nor MAPK activation in MCF-7/ADR cells (Fig.
5). The addition of glutamate, however, rescued cells from
the cytotoxicity (unpublished data), decreased the MAPK
activation, and the length of time of activation (Fig. 6). Al-
though glutamine can be converted into glutamate by the
enzyme glutamate synthase, it may be that MCF-7/ADR cells
are deficient or have a defect in this enzyme. Glutamate can
be converted by the cell into α-ketoglutarate which can en-
ter the tricarboxylic acid cycle and generate ATP. We also
found that MAPK activation is dependent on the concentra-
tion of glucose (Fig. 4). This suggests a role for the energy
supply within a cell regulating the activation of MAPK, AP-
1 transcription factors, and bFGF. In addition, the effects of
glucose deprivation are seen in other pathways like those
involving JNK which is also activated (data not shown).
It is known that MAPK is activated by phosphorylation at
tyrosine and threonine [21]. The direct upstream activator of
MAPK is MAP kinase or MEK [35]. MEK is activated by
phosphorylation on serine and possibly threonine residues
[36]. Some evidence has indicated the Raf proto-oncogene
product, which is a serine/threonine kinase activated by both
receptor and nonreceptor tyrosine kinases via activation of
p21Ras, activates MEK [37, 38]. Raf has also been shown
to be activated by protein kinase C (PKC) [39]. The data that
we have presented (Fig. 7) shows that glucose deprivation
results in a greater than three fold increase in MEK, RAF,
RAS, and PKC activity.
At this time only speculation can be made concerning the
mechanism of MAPK activation with glucose deprivation. In
neuronal cells, glucose deprivation has been shown to pro-
mote the production of free radicals [40], and free radicals
in turn can activate MAPK [33]. We have measured the lev-
els of catalase in MCF-7 and MCF-7/ADR cells and found
that MCF-7 cells have four times as much catalase as MCF-
7/ADR cells (unpublished data). We have observed that the
addition of the free radical scavenger N-acetylcysteine at
concentrations of 1 mM can prevent glucose deprivation in-
duced MAPK activation in MCF-7/ADR cells (unpublished
data). Obviously, further studies at the biochemical level are
necessary to understand the mechanism of MAPK activation.
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